Plethora Solutions

SUMMARY OF PRODUCT CHARACTERISTICS

Download Summary of Product Characteristics (PDF)

Last updated: 6th March 2018 - UK/Fortacin/002

This Product is a proprietary development stage pharmaceutical although the European MAA has been authorized by the European Commission. Information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.



Copyright 2013 © Plethora Solutions Limited and Plethora Solutions Holdings PLC. All Rights Reserved.